Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 3:23 pm Sale | 13G | OCUPHIRE PHARMA INC OCUP | Sooch Mina | 1,187,352 5.5% | -98,910 (-7.69%) | View |
| 2022-05-17 4:37 pm Purchase | 13G | OCUPHIRE PHARMA INC OCUP | Richmond Brothers Inc. | 1,193,633 6.2% | 776,219 (+185.96%) | View |
| 2022-02-14 4:10 pm Unchanged | 13G | OCUPHIRE PHARMA INC OCUP | Sooch Mina | 1,286,262 6.7% | 0 (Unchanged) | View |
| 2022-02-14 09:53 am Unchanged | 13G | OCUPHIRE PHARMA INC OCUP | Altium Capital Management LP | 2,678,883 4.99% | 0 (Unchanged) | View |
| 2022-01-18 11:17 am Purchase | 13G | OCUPHIRE PHARMA INC OCUP | Empery Asset Management LP | 3,063,498 4.99% | 384,615 (+14.36%) | View |
| 2021-03-26 4:05 pm Purchase | 13G | OCUPHIRE PHARMA INC OCUP | Apexian Pharmaceuticals Inc. | 779,993 7.136% | 779,993 (New Position) | View |
| 2021-03-16 7:58 pm Purchase | 13G | OCUPHIRE PHARMA INC OCUP | Sooch Mina | 1,286,262 11.8% | 1,286,262 (New Position) | View |
| 2021-02-16 09:17 am Purchase | 13G | OCUPHIRE PHARMA INC OCUP | Altium Capital Management LP | 2,678,883 9.99% | 2,087,867 (+353.27%) | View |
| 2021-02-02 10:26 am Purchase | 13G | OCUPHIRE PHARMA INC OCUP | Empery Asset Management LP | 2,678,883 9.99% | 2,087,867 (+353.27%) | View |
| 2020-11-16 2:21 pm Purchase | 13G | OCUPHIRE PHARMA INC OCUP | Richmond Brothers Inc. | 417,414 5.8% | 417,414 (New Position) | View |
| 2020-11-16 2:00 pm Purchase | 13G | OCUPHIRE PHARMA INC OCUP | Altium Capital Management LP | 591,016 8.3% | 591,016 (New Position) | View |
| 2020-11-12 10:38 am Purchase | 13G | OCUPHIRE PHARMA INC OCUP | Empery Asset Management LP | 591,016 8.33% | 591,016 (New Position) | View |
| 2020-08-10 5:02 pm Purchase | 13G | REXAHN PHARMACEUTICALS INC RNN | ARMISTICE CAPITAL LLC | 44,145 1% | 44,145 (New Position) | View |